You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 TB-HIV co-infection management

From: The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study

TB-HIV co-infected study participants
CD4+ T-cell count: no. (%) 6 (33)
   CD4+ T-cells/μL: median (range) 318 (18-739)
   CD4+ T-cells <200 2
   CD4+ T-cells 200-350 1
   CD4+ T-cells >350 3
   CD4+ T-cells unknown 12
Anti-retroviral therapy: no. (%) 4/18 (22)
   Commenced prior to TB diagnosis 1
   Commenced during TB treatment 1
   Commenced after TB treatment completed 2
ART type  
   AZT/3TC/nevirapine 3
   AZT/3TC/efavirenz 1
Co-trimoxazole: no. (%) 11/18 (61)